23.6.2025Too clean is unhealthy
8.5.2025Alkaloids derived from tree bark destroy cancer cells
27.3.2025Vinca alkaloids: Madagascar’s gift to cancer treatment
6.2.2025Genetic testing improves medication safety and effectiveness
26.12.2024The ComPatAI consortium uses large datasets to create an AI learning model for pathology
14.11.2024Microbiota affects the immune system
21.10.2024The skin’s wide range of microbiota improves the immune system
30.9.2024New drug targets from RNA-binding proteins
31.8.2024New machine learning method speeds up drug screening hundred-fold
22.7.2024Mapping the coffee genome to improve disease resistance
25.6.2024Why do some get the severe form of COVID-19?
30.5.2024An AI model that understands health data warns of future diseases
29.4.2024An infrastructure for genomic data
1.4.2024European research community preparing for next pandemic
8.3.2024Evolutionary dynamics of viruses and other microbes affect human health
2.3.2024A million European genomes
20.2.2024Efficient transfer and analysis of biological image data through web interfaces
23.1.2024Improving breast cancer treatment prognoses with liquid biopsy
15.12.2023The European Health Data Space: health data moves across borders for research purposes
16.11.2023New method for measuring gut microbiota
31.10.2023Purifying mining wastewater with plant-associated microbes
29.9.2023Artificial intelligence helps researchers find suitable drugs based on patient’s genetic data and cancer cell samples
1.9.2023Combining data from different sources for personalised treatment
15.8.2023Better treatments for leukaemia
10.6.2023MicroRNAs may reveal type 1 diabetes
16.5.2023Single-cell RNA sequencing enabling individual disease treatment
12.4.2023Tissue samples analysed with Sensitive Data (SD) services provide new information on celiac disease and other autoimmune diseases
20.3.2023DNA isolated from Baltic Sea sediment shedding light on climate change and biodiversity
27.2.2023Organoids grown from stem cells boost cancer research
19.12.2022Sensitive Data (SD) services for Research: with a few clicks a researcher can launch a personal secure computing environment
30.11.2022Microbiota in permafrost play an important role in climate change
20.10.2022Reusable, accurately described and high-quality data – tools created by the research community for agile data management
29.9.2022Gene sequencing used for study of structure and functioning of microbial communities in oceans
1.9.2022Antibiotic-resistant bacteria are a global problem
23.8.2022Personalised medicine against cancer and viruses
30.6.2022Studying the human microbiome is a key towards holistic understanding of our health
23.5.2022FINRISK: one of the world’s longest-running population survey time series
8.4.2022Combining biobank data with data from health registers enables research towards personalised treatment
3.3.2022Finnish research team sequences the genomes of thousands of individuals with diabetes to look for genetic risk factors
10.2.2022BIGPICTURE helps pathology go digital
30.12.2021Sensitive data infrastructure
23.11.2021In the future, an algorithm may diagnose glaucoma from fundus photos
26.10.2021Patient data creating better artificial intelligence models
15.9.2021Teaching an algorithm to identify cancer from sequence data
3.12.2020Efficient processing and sharing of data improving disease diagnosis and treatment
10.11.2020Bioinformatics to revolutionise healthcare: Efficient data processing speeds up diagnoses and enables personalised drug treatments
27.8.2020Tissue samples into digital images, interpreted by artificial intelligence
9.6.2020Digital pathology speeds up diagnosis
18.5.2020Searching markers for breast cancer by machine learning
8.4.2020Metabolomics measures and analyses metabolic changes caused by illness, diet or medication
1.3.2020Deep learning algorithms help in breast cancer screening
13.2.2020All breast cancer risk factors evaluated with AI
6.2.2020A dog can smell diseases
2.12.2019ELIXIR Compute Platform for life and health sciences
18.11.2019New bioinformatics methods and measurement technologies call for continuously updated courses and analysis software
30.10.2019No need to turn up personally: SisuID improves electronic authentication
30.9.2019Risk assessment of cardiovascular diseases for all citizens
20.8.2019Federated user ID management: a single identity giving access to numerous bioinformatics services
4.9.2019Targeted treatment for venous diseases with vascular system modelling
4.7.2019Research on rare genetic disorders can be utilised in understanding the mechanisms behind even more common diseases
3.6.2019VEIL.AI: patient data in a veil
20.5.2019Biocenter Oulu: technology services for biomedical research
23.4.2019Mouse models provide insights into the causal mechanisms of diseases
4.3.2019Euro-BioImaging: imaging infrastructure
26.2.2019Imaging helps to highlight significance of data
14.1.2019Data harmony and standards: data must be processed, described and stored by uniform means
10.12.2018Hundreds of genes could lie behind a single disease
5.11.2018Help from the Finnish genome for the prevention of cardiovascular diseases
8.10.2018Disease prediction models are becoming more accurate thanks to the computational methods
11.9.2018Genetic data under control and in the desired format
23.8.2018Massive data management project: Finns’ heredity is collected and safeguarded
14.6.2018Half of all drug ingredients affect only three protein families
12.6.2018Looking for a good drug
29.5.2018Quick DNA analysis of patient samples with artificial intelligence
7.5.2018Secrets of the intestines
4.4.2018Algorithm determines the appropriate drug
19.3.2018Bank of million patient samples
20.2.2018Mapping the genomes of all organisms enables the development of new vaccines and medicines
7.2.2018Ordered and secured
2.11.2017Striving for a national service to utilise genomic data in health care
11.8.2017Better harvests on the horizon? Data will also be harvested
19.6.2017Microbes and climate change
21.5.2017Storing the whole genome of the Finnish population? The data will benefit disease research
6.4.2017”Smart life insurances” offered: human biological data is only useful when interpreted correctly
15.1.2016New drug molecules through determining the structure of proteins
26.10.2015BBMRI.fi: an IT Infrastructure for shared biobanks
24.9.2015Fighting cancer with mathematics
10.8.2015Saimaa ringed seal aids the study of population genomes
1.8.2015Webmicroscope stores tissue samples in the cloud
15.7.2015Pups and Pooches Behind Genetic Discoveries in Human Diseases Canine Genetic Research Benefits from ELIXIR Databases
5.6.2015Life sciences in European cloud
Immune-mediated diseases, such as allergies, asthma and autoimmune diseases, have increased with urbanisation. Researchers suggest that the reason for this is the excessive cleanliness of our environment, as a result of which we have lost touch with nature and its microbes. Adjunct Professor Olli Laitinen studies the health effects of microbial exposure at Tampere University. He also serves as Chief Science Officer at Uute Scientific Ltd. The company produces an extract containing inactivated microbes, which can be used as a raw material in cosmetics, for example.
Microbial exposure can be easily increased by spending time in nature and coming into contact with soil. Handling natural materials with a wide range of microbes changes the microbiota of the body. Laitinen’s projects explore solutions suitable for urban areas to influence the prevalence of immune disorders by modifying the green environment and consumer products.
Laitinen believes that microbial exposure starts at birth.
“When we are born, our bodies are not immunologically complete. At the moment of birth, we encounter practically millions of different life forms. That’s when our immune system starts to learn what is dangerous and what is harmless.”
Laitinen stresses that the root cause of today’s immune-mediated diseases is the fact that we have lost touch with nature and live in an environment that is too clean.
“Humans have lived in natural conditions for hundreds of thousands of years. Mothers have given birth squatting on animal hides, and babies have been wrapped in plant materials. From our first moments, we have been in contact with the soil and nature. We adapted to this exposure.”
“At birth, our bodies get a full blast of microbes and our immune system gets to work. At that point, it is important for the immune system to be able to distinguish between what is dangerous and what is harmless. What is harmless is, of course, our own bodies. However, the immune system also needs to recognise that not all external exposure is dangerous either. Therefore, it is not wise to develop allergies to animal dander, for example. The immune system must learn which microbes are genuinely dangerous and pathogenic.”
Childbirth in a hospital is quite sterile compared to nature.
“If you’re in an environment where the immune system doesn’t get a lot of learning material, the system starts act so that anything external is potentially dangerous. This leads to allergies and asthma, atopic dermatitis, or worse: a situation where the immune system cannot distinguish between the body’s own cells and pathogens, so it starts destroying the former, leading to various autoimmune diseases.”
Promising results have now emerged on how a biodiverse environment can prevent the development of autoimmune diseases, such as type 1 diabetes. Laitinen refers to a part of Noora Nurminen’s doctoral thesis at Tampere University, where she studied the amount of green environment and its impact on the development of type 1 diabetes.
“Type 1 diabetes occurs when inflammatory cells in the immune system are activated in the pancreas and destroy insulin-producing cells. Nurminen examined a cohort of more than 10,000 children to learn how the growing environment during the first year of life influenced the development of diabetes. The results showed that an agrarian environment was healthy for children. Children living in rural areas did not develop diabetes or the autoimmune process leading to it as often as children living in urban areas, or their disease process started much later than that of children living in urban areas.”
The diversity of the microbiota in the human body has declined considerably, especially in the Western world. According to one estimate, urbanised people have 60% of their original microbiota remaining on the skin, and only 50% in the gut. In some areas of the United States, the microbial loss is even higher. As it happens, citizens of the U.S. have more inflammatory diseases than citizens of other countries.
Olli Laitinen believes that the immune system of newborns should start receiving training in the form of exposure to nature when leaving the maternity ward at the latest. Without exposure to nature and its microbes, our bodies’ immune defences cannot function properly. The overreacting immune system may lead to diseases. For example, in the case of allergy, the body misinterprets pollen as a virus.
“We base our research on the function of the immune system and the disruption caused by lack of exposure to nature. The natural role of immunoglobulin E has been to fight parasitic infections, but now that there are far fewer of them, IgE is a free agent looking for new tasks. Such as reacting to pollen.”
Immunoglobulins, or antibodies, are proteins produced by the cells of the body’s defence system. The role of antibodies is to help the defence system destroy invaders, such as bacteria and viruses. IgE-type antibodies have been deprived of their natural activity due to excessive hygiene and sterility, and are therefore inactive. Now, the IgE response is incorrectly activated e.g. against the proteins in pollen, causing allergic hypersensitivity reactions.
Immunoglobulin E is found in allergies and allergic diseases. In allergies, the body produces it to fight off things like pollen or certain foods. The antibody attaches to cells in the skin and mucous membranes and releases histamine. This is what makes us sneeze, our breathing to become obstructed and our eyes swell shut. In developing countries, where parasitic infections are more common, IgE often occurs at high levels without any allergic symptoms.
The “false enemies” of immunoglobulins are a great example of biodiversity loss, which also applies to the microbiota.
“Now that we’re being sold a lot of antibacterial substances, we are actually cleaning away all the bacteria. This is not desirable. It would be better to have a well-established microbiota around us, because that helps us avoid sudden, major changes.”
Changes in the microbiota can cause antibiotic resistance, which is a big problem. Antibiotic-resistant bacteria carry resistance genes and often become dominant in microbial populations.
“Pathogens are usually fast-growing microbes. The abundance of pathogens increases the exchange of genes between them, strengthening their resistance to antibiotics,” says Laitinen, who has also studied antibiotic resistance.
“Hopefully, in the future we will have a safe amount of diverse microbes in our environment so that antibiotic-resistant bacteria cannot thrive.”
Atopic dermatitis is a common, partly hereditary disease affecting about 20–30% of the population in Finland. Its symptoms include itchiness, dryness, roughness, redness and breakouts of the skin. This is due to abnormal immune system function.
“In the Nordic countries, atopic dermatitis is common. It has been observed that many immune-mediated diseases become more prevalent at the population level as we move northwards.”
The PREVALL project, led by the Universities of Tampere and Helsinki, has studied the impact of plant- and soil-based materials on children’s allergies. The project has examined whether it would be possible to prevent the development of atopic dermatitis in babies. Children with both parents diagnosed with atopic dermatitis were included in the study.
“In that case, the child has about a 40% risk of developing the same disease,” Laitinen points out.
In Johanna Kalmari’s and Iida Mäkelä‘s study, a joint project between Uute Scientific and Tampere University, people suffering from atopic dermatitis were given microbial cream containing the extract developed by Uute Scientific. The microbes were not alive, but the cream contained microbial components to which the body and immune defence system can react. In other words, exposure to nature was administered through a cream. The subjects started using the cream in late summer and autumn, as atopic skin gets worse in winter due to dry air and lower temperatures. The lower amount of natural light also has an impact. The subjects used the cream at least three times a week. The researchers took various samples from the subjects, examining the water permeability and redness of the skin, which are indicators of inflammation.
“The biggest difference was seen in the use of medication. The group that used the microbial extract containing cream needed significantly less medication during the trial period of 7 months. The microbial extract containing cream was able to prevent skin deterioration. The cream is a so-called “nature exposure remedy”. It’s a supportive form of treatment that allows patients to use less medication.”
The newest frontier is no more and no less than space itself.
“Astronauts suffer from various skin problems. Not surprisingly, the International Space Station has a very poor microbial environment. Our extract could be taken into space. Discussions have been held with the European Space Agency (ESA) on the use of the cream.”
Olli Laitinen’s research group at Tampere University and Uute Scientific have used the computing and sensitive data services of the CSC, the ELIXIR Node of Finland in their research. Over the course of more than 10 years, the group has been involved in sampling more than 500 individuals, including infants, kindergarten-age children and adults. Some of the data is stored in CSC’s data security environment.
Uute Scientific’s microbial extract is made by combining various plant composts. It contains inactive microbes, which means they are harmless. However, the immune system recognises microbes, microbial particles and also destroyed pathogens. The material was originally developed at the Universities of Helsinki and Tampere. Its biodiversity makes it a unique raw material for cosmetics and other consumer products worldwide. It contains at least 600 different species of microbes.
Ari Turunen
23.6.2025
Read article in PDF